{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:45:17Z","timestamp":1782722717479,"version":"3.54.5"},"reference-count":89,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Seasonal affective disorder (SAD) occurs in two main forms: winter-pattern SAD, associated with depressive symptoms during shorter, darker days; and summer-pattern SAD, linked to mood disturbances during longer, hotter days. SAD may develop into a chronic condition with recurring depressive episodes. Risk factors for SAD include geographic latitude, age, gender, genetic predisposition, and lifestyle. Sleep disturbances, such as insomnia, hypersomnia, and circadian rhythm disruptions, are common and can amplify emotional symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This review explores the clinical features and management strategies for insomnia associated with SAD, focusing on the potential of benzodiazepines (BZDs), in particular lormetazepam.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Controversies surround current nonpharmacological and pharmacological strategies for managing sleep disorders in SAD. This review emphasizes the importance of using more effective treatments for insomnia associated with SAD, currently an unmet need. In particular, clinical evidence supports the potential benefits of intermittent hypnotic BZDs to treat insomnia. Among the BZDs, short-term or intermittent use of lormetazepam is an effective treatment option in the management of insomnia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Insomnia associated with SAD is an important symptom to monitor because it impacts the patient\u2019s quality of life. BZDs, including lormetazepam, are a standard short-treatment option for insomnia that could improve the sleep symptoms associated with SAD. Comparative clinical trials of the efficacy and safety of lormetazepam in this patient population are required to confirm this.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2025.1667086","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T06:30:28Z","timestamp":1768372228000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Insomnia in seasonal affective disorder: considering the use of benzodiazepines with a focus on lormetazepam"],"prefix":"10.3389","volume":"16","author":[{"given":"Giovanni","family":"Biggio","sequence":"first","affiliation":[{"name":"Department of Life and Environmental Sciences, University of Cagliari, Cittadella Universitaria di Monserrato","place":["Cagliari, Italy"]},{"name":"Institute of Neurosciences, National Research Council (C.N.R.), Cittadella Universitaria di Monserrato","place":["Cagliari, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Mencacci","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Mental Health, Azienda Socio Sanitaria Territoriale (ASST) Fatebenefratelli Sacco","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12888-021-03313-z","article-title":"Seasonal sensitivity and psychiatric morbidity: study about seasonal affective disorder","volume":"21","author":"Fonte","year":"2021","journal-title":"BMC Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.copsyc.2019.08.023","article-title":"Sleep in seasonal affective disorder","volume":"34","author":"Wescott","year":"2020","journal-title":"Curr Opin Psychol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1212028","article-title":"Long-term use of benzodiazepines in chronic insomnia: a European perspective","volume":"14","author":"Soyka","year":"2023","journal-title":"Front Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211069096","article-title":"Comparative safety of chronic versus intermittent benzodiazepine prescribing in older adults: a population-based cohort study","volume":"36","author":"Davies","year":"2022","journal-title":"J Psychopharmacol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-020-02209-8","article-title":"Dependence liability of lormetazepam: are all benzodiazepines equal? The case of the new i.v. lormetazepam for anesthetic procedures","volume":"127","author":"Horowski","year":"2020","journal-title":"J Neural Transm (Vienna)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2003.5.4\/awirzjustice","article-title":"Chronobiology and mood disorders","volume":"5","author":"Wirz-Justice","year":"2003","journal-title":"Dialogues Clin Neurosci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.33696\/mentalhealth.4.025","article-title":"Bipolar disorders and seasonality","volume":"4","author":"Bourin","year":"2024","journal-title":"J Ment Health Disord"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10091897","article-title":"Validity and usage of the Seasonal Pattern Assessment Questionnaire (SPAQ) in a French population of patients with depression, bipolar disorders and controls","volume":"10","author":"Reynaud","year":"2021","journal-title":"J Clin Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1001\/archpsyc.1984.01790120076010","article-title":"Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy","volume":"41","author":"Rosenthal","year":"1984","journal-title":"Arch Gen Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.144.12.1602","article-title":"Seasonal affective disorder with summer depression and winter hypomania","volume":"144","author":"Wehr","year":"1987","journal-title":"Am J Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/archpsyc.1996.01830010049008","article-title":"Seasonal changes in mood and behavior. The role of genetic factors","volume":"53","author":"Madden","year":"1996","journal-title":"Arch Gen Psychiatry"},{"key":"B12","volume-title":"Seasonal affective disorder","author":"Munir","year":"2024"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1017\/s1092852900019593","article-title":"The diagnosis, symptomatology, and epidemiology of seasonal affective disorder","volume":"10","author":"Magnusson","year":"2005","journal-title":"CNS Spectr"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1708\/283.3280","article-title":"Prevalence of seasonal affective disorder in Italy [Italian","volume":"42","author":"Pacitti","year":"2007","journal-title":"Riv Psichiatr"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/s0889-8529(05)70247-4","article-title":"Mood disorders and menopause","volume":"26","author":"Pearlstein","year":"1997","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12072","article-title":"Seasonal variation of manic and depressive symptoms in bipolar disorder","volume":"15","author":"Akhter","year":"2013","journal-title":"Bipolar Disord"},{"key":"B17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41398-018-0246-z","article-title":"Genome-wide association study of seasonal affective disorder","volume":"8","author":"Ho","year":"2018","journal-title":"Transl Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww043","article-title":"Seasonal difference in brain serotonin transporter binding predicts symptom severity in patients with seasonal affective disorder","volume":"139","author":"Mc Mahon","year":"2016","journal-title":"Brain"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/178564","article-title":"Seasonal affective disorder: an overview of assessment and treatment approaches","volume":"2015","author":"Melrose","year":"2015","journal-title":"Depress Res Treat"},{"key":"B20","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1210\/er.2018-00084","article-title":"Melatonin as a hormone: new physiological and clinical insights","volume":"39","author":"Cipolla-Neto","year":"2018","journal-title":"Endocr Rev"},{"key":"B21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/jnc.15012","article-title":"GABAergic mechanisms in the suprachiasmatic nucleus that influence circadian rhythm","volume":"157","author":"Ono","year":"2021","journal-title":"J Neurochem"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.26236","article-title":"The influence of season on glutamate and GABA levels in the healthy human brain investigated by magnetic resonance spectroscopy imaging","volume":"44","author":"Spurny-Dworak","year":"2023","journal-title":"Hum Brain Mapp"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0602425103","article-title":"The circadian basis of winter depression","volume":"103","author":"Lewy","year":"2006","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1017\/s003329172100283x","article-title":"Elusive hypersomnolence in seasonal affective disorder: actigraphic and self-reported sleep in and out of depressive episodes","volume":"53","author":"Wescott","year":"2023","journal-title":"Psychol Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e14035","DOI":"10.1111\/jsr.14035","article-title":"The European Insomnia Guideline: an update on the diagnosis and treatment of insomnia 2023","volume":"32","author":"Riemann","year":"2023","journal-title":"J Sleep Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-12112-3","article-title":"Evaluation and management of insomnia in the clinical practice in Italy: a 2023 update from the Insomnia Expert Consensus Group","volume":"271","author":"Palagini","year":"2024","journal-title":"J Neurol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2018.08.071","article-title":"Depressive mood and circadian rhythms disturbances as outcomes of seasonal affective disorder treatment: A systematic review","volume":"241","author":"Menculini","year":"2018","journal-title":"J Affect Disord"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2003.5.4\/npraschakrieder","article-title":"Treatment of seasonal affective disorders","volume":"5","author":"Praschak-Rieder","year":"2003","journal-title":"Dialogues Clin Neurosci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2024.03.053","article-title":"Lifestyle modification as intervention for seasonal affective disorder: a systematic review","volume":"174","author":"Rothenberg","year":"2024","journal-title":"J Psychiatr Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e14025","DOI":"10.1111\/jsr.14025","article-title":"Disseminating cognitive behavioural therapy (CBT) for insomnia at scale: capitalising on the potential of digital CBT to deliver clinical guideline care","volume":"32","author":"Espie","year":"2023","journal-title":"J Sleep Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsad169","article-title":"Disseminating sleep education to graduate psychology programs online: a knowledge translation study to improve the management of insomnia","volume":"46","author":"Meaklim","year":"2023","journal-title":"Sleep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2023.101746","article-title":"Efficacy and tolerability of pharmacological treatments for insomnia in adults: A systematic review and network meta-analysis","volume":"68","author":"Yue","year":"2023","journal-title":"Sleep Med Rev"},{"key":"B33","volume-title":"GABA receptor","author":"Chen","year":"2025"},{"key":"B34","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41398-024-03087-4","article-title":"Orexin receptor antagonists in the treatment of insomnia associated with psychiatric disorders: a systematic review","volume":"14","author":"Kishi","year":"2024","journal-title":"Transl Psychiatry"},{"key":"B35","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1038\/s41467-022-31591-y","article-title":"Orexin neurons inhibit sleep to promote arousal","volume":"13","author":"De Luca","year":"2022","journal-title":"Nat Commun"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e14196","DOI":"10.1111\/jsr.14196","article-title":"Early experience with the new DORA daridorexant in patients with insomnia disorder and comorbid mental disturbances: Results of a naturalistic study with 3\u2009months follow-up","volume":"33","author":"Palagini","year":"2024","journal-title":"J Sleep Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/wnf.0000000000000499","article-title":"Assessment of suvorexant and eszopiclone as alternatives to benzodiazepines for treating insomnia in patients with major depressive disorder","volume":"45","author":"Shigetsura","year":"2022","journal-title":"Clin Neuropharm"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00878-9","article-title":"Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis","volume":"400","author":"De Crescenzo","year":"2022","journal-title":"Lancet"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12720","article-title":"Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties","volume":"171","author":"Guardiola-Lemaitre","year":"2014","journal-title":"Br J Pharmacol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2025.174003","article-title":"Agomelatine with cognitive behavioral therapy reduces insomnia severity index and subjective units of distress scores than initial-dose clonazepam in moderate to severe insomnia patients: A quasi-experimental study","volume":"251","author":"Prabahar","year":"2025","journal-title":"Pharmacol Biochem Behav"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2017.294","article-title":"Neuronal mechanisms for sleep\/wake regulation and modulatory drive","volume":"43","author":"Eban-Rothschild","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsmc.2010.08.003","article-title":"Neuropharmacology of sleep and wakefulness","volume":"5","author":"Watson","year":"2010","journal-title":"Sleep Med Clin"},{"key":"B43","volume-title":"Benzodiazepines","author":"Bounds","year":"2024"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.1060949","article-title":"GABAA receptor subtypes and benzodiazepine use, misuse, and abuse","volume":"13","author":"Engin","year":"2023","journal-title":"Front Psychiatry"},{"key":"B45","first-page":"72","article-title":"Farmacocinetica delle benzodiazepine","volume-title":"Le benzodiazepine, edizioni","author":"Gatti","year":"2000"},{"key":"B46","first-page":"4","article-title":"Benzodiazepine hypnotics: sorting the pharmacokinetic facts","author":"Greenblatt","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"B47","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12877-016-0363-6","article-title":"The association between benzodiazepine use and sleep quality in residential aged care facilities: a cross-sectional study","volume":"16","author":"Chen","year":"2016","journal-title":"BMC Geriatrics"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1159\/000502518","article-title":"Call for action: benzodiazepine prescription prevalence analysis shows off-label prescription in one in eleven citizens","volume":"25","author":"Lopez-Pelayo","year":"2019","journal-title":"Eur Addict Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/jsr.12594","article-title":"European guideline for the diagnosis and treatment of insomnia","volume":"26","author":"Riemann","year":"2017","journal-title":"J Sleep Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.6470","article-title":"Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline","volume":"13","author":"Sateia","year":"2017","journal-title":"J Clin Sleep Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00558","article-title":"Expert opinions and consensus recommendations for the evaluation and management of insomnia in clinical practice: joint statements of five Italian scientific societies","volume":"11","author":"Palagini","year":"2020","journal-title":"Front Psychiatry"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1053\/smrv.2000.0122","article-title":"Hypnotic medication in the treatment of chronic insomnia: non nocere! Doesn\u2019t anyone care","volume":"4","author":"Kramer","year":"2000","journal-title":"Sleep Med Rev"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1715050","article-title":"Our other prescription drug problem","volume":"378","author":"Lembke","year":"2018","journal-title":"N Engl J Med"},{"key":"B54","unstructured":"Lormetazepam 0.5mg tablets: summary of product characteristics\n          \n          \n          \n          2021"},{"key":"B55","unstructured":"Lormetazepam 1mg tablets: summary of product characteristics\n          \n          \n          \n          2021"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1982.tb01422.x","article-title":"A radioreceptor assay to study the affinity of benzodiazepines and their receptor binding activity in human plasma including their active metabolites","volume":"13","author":"Dorow","year":"1982","journal-title":"Br J Clin Pharmacol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyz007","article-title":"An insight into Z-drug abuse and dependence: An examination of reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions","volume":"22","author":"Schifano","year":"2019","journal-title":"Int J Neuropsychopharmacol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.clinthera.2005.01.003","article-title":"Psychomotor performance in healthy young adult volunteers receiving lormetazepam and placebo: a single-dose, randomized, double-blind, crossover trial","volume":"27","author":"Fabbrini","year":"2005","journal-title":"Clin Ther"},{"key":"B59","article-title":"Lormetazepam - a benzodiazepine derivative without hangover effect? A double-blind study with chronic insomniacs in a general practice setting","volume":"19","author":"Heidrich","year":"1981","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.5414\/cpp40304","article-title":"Lormetazepam effects on daytime vigilance, psychomotor performance and simulated driving in young adult healthy volunteers","volume":"40","author":"Iudice","year":"2002","journal-title":"Int J Clin Pharmacol Ther"},{"key":"B61","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/BF00544013","article-title":"The effects of lormetazepam on aspects of sleep and early morning performance","volume":"25","author":"Subhan","year":"1983","journal-title":"Eur J Clin Pharmacol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200727050-00003","article-title":"Role of lormetazepam in the treatment of insomnia in the elderly","volume":"27","author":"De Vanna","year":"2007","journal-title":"Clin Drug Investig"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1017120","article-title":"On the distribution of REM and NREM sleep under two benzodiazepines with comparable receptor affinity but different kinetic properties","volume":"20","author":"Kubicki","year":"1987","journal-title":"Pharmacopsychiatry"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000529","article-title":"The role of benzodiazepines in common conditions: a narrative review focusing on lormetazepam","volume":"39","author":"Pallanti","year":"2024","journal-title":"Int Clin Psychopharmacol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199504000-00009","article-title":"Antagonizing the effects of experimentally induced sleep disturbance in healthy volunteers by lormetazepam and zolpidem","volume":"15","author":"Cluydts","year":"1995","journal-title":"J Clin Psychopharmacol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1982.tb01398.x","article-title":"Hypnotic activity and effects on performance of lormetazepam and camazepam--analogues of temazepam","volume":"13","author":"Nicholson","year":"1982","journal-title":"Br J Clin Pharmacol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2165\/00023210-200418050-00003","article-title":"Residual effects of hypnotics: epidemiology and clinical implications","volume":"18","author":"Vermeeren","year":"2004","journal-title":"CNS Drugs"},{"key":"B68","volume-title":"MINIAS (lormetazepam): summary of product characteristics [Italian]","year":"2023"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1982.tb02645.x","article-title":"Dose-response studies of lormetazepam: efficacy, side effects, and rebound insomnia","volume":"22","author":"Kales","year":"1982","journal-title":"J Clin Pharmacol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1177\/030006058501300102","article-title":"A double-blind controlled subjective study of a new pharmaceutical preparation of lormetazepam versus placebo in patients with chronic sleep disturbances","volume":"13","author":"Meco","year":"1985","journal-title":"J Int Med Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/16.3.233","article-title":"A comparison between visual and computer assessment of sleep onset latency and their application in a pharmacological sleep study","volume":"16","author":"Jobert","year":"1993","journal-title":"Sleep"},{"key":"B72","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/030006058100900309","article-title":"Comparative efficacy of lormetazepam (Noctamid) and diazepam (Valium) in 100 out-patients with insomnia","volume":"9","author":"Sastre y Hernandez","year":"1981","journal-title":"J Int Med Res"},{"key":"B73","article-title":"Comparative study of lormetazepam and flurazepam in the treatment of insomnia","volume":"6","author":"Melo de Paula","year":"1984","journal-title":"Clin Ther"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1097\/01.yic.0000132776.05964.01","article-title":"Lormetazepam in depressive insomnia: new evidence of phase-response effects of benzodiazepines","volume":"19","author":"Benedetti","year":"2004","journal-title":"Int Clin Psychopharmacol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.2147\/RMHP.S31745","article-title":"Lormetazepam addiction: data analysis from an Italian medical unit for addiction","volume":"5","author":"Faccini","year":"2012","journal-title":"Risk Manag Healthc Policy"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-019-02101-8","article-title":"High-dose lormetazepam dependence: strange case of Dr","volume":"14","author":"Faccini","year":"2019","journal-title":"Jekyll Mr. Hyde. Intern Emerg Med"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12678","article-title":"Characterization of benzodiazepine misuse and comorbidities in patients with alcohol use disorder","volume":"35","author":"Lopez","year":"2021","journal-title":"Fundam Clin Pharmacol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1159\/000117950","article-title":"Study with lormetazepam as a hypnotic in general practice","volume":"9","author":"Poldinger","year":"1983","journal-title":"Neuropsychobiology"},{"key":"B79","first-page":"3","article-title":"Benzodiazepine 2015: il vantaggio del buonsenso [in Italian","volume":"1","author":"Torta","year":"2016","journal-title":"Rivista Societ\u00e0 Italiana di Med Generale"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-2999(02)02191-x","article-title":"Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes","volume":"451","author":"Sanna","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1177\/0269881109106927","article-title":"Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics","volume":"24","author":"Nutt","year":"2010","journal-title":"J Psychopharmacol"},{"key":"B82","unstructured":"FDA adds Boxed Warning for risk of serious injuries caused by sleepwalking with certain prescription insomnia medicines [FDA Drug Safety Podcast]\n          \n          \n          \n          2022"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3502","article-title":"Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes","volume":"10","author":"Rudolph","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R112.386664","article-title":"Structure, function, and modulation of GABA(A) receptors","volume":"287","author":"Sigel","year":"2012","journal-title":"J Biol Chem"},{"key":"B85","first-page":"1120 p","volume-title":"Diagnostic and statistical manual of mental disorders, fifth edition, text revision (DSM-5-TR","year":"2022"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1093\/arclin\/acx120","article-title":"The residual medium and long-term cognitive effects of benzodiazepine use: an updated meta-analysis","volume":"33","author":"Crowe","year":"2018","journal-title":"Arch Clin Neuropsychol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"e0127836","DOI":"10.1371\/journal.pone.0127836","article-title":"Association between benzodiazepine use and dementia: A meta-analysis","volume":"10","author":"Zhong","year":"2015","journal-title":"PLoS One"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-73288-1_13","article-title":"Anterograde and retrograde amnesia after lormetazepam and flunitrazepam","volume":"6","author":"Ott","year":"1988","journal-title":"Psychopharmacol Ser"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3399\/bjgpopen18X101626","article-title":"Long-term use of benzodiazepines and Z drugs: a qualitative study of patients\u2019 and healthcare professionals\u2019 perceptions and possible levers for change","volume":"3","author":"Mokhar","year":"2019","journal-title":"BJGP Open"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1667086\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T06:30:31Z","timestamp":1768372231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1667086\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":89,"alternative-id":["10.3389\/fpsyt.2025.1667086"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2025.1667086","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"article-number":"1667086"}}